The global Phase III EMPEROR trial (NCT06872125) will evaluate the safety and efficacy of zorevunersen, a novel antisense ...

Because Dravet syndrome is a rare, complex medical disease that is lifelong, it’s important for families to find comprehensive care.

People who have Dravet syndrome, a rare and severe form of epilepsy, usually experience their first seizure within the first year of life. (1) These early seizures, which are typically triggered ...

Analysts have given Stoke Therapeutics a total of 3 ratings, with the consensus rating being Buy. The average one-year price target is $29.0, indicating a potential 121.37% upside.

B was first diagnosed with Lennox-Gastaut syndrome (LGS) due to the frequency and severity of his seizures. He was later confirmed to have the genetic mutation that indicates Dravet's.

LONDON-- (BUSINESS WIRE)--The Dravet syndrome treatment market is set to grow by USD 396.15 million accelerating at a CAGR of over 9%, during the period spanning over 2020-2024.

Grace has Dravet syndrome, a rare and severe form of epilepsy that usually begins within the first year of life. A 2015 study estimates the condition affects up to 1 in 16,000 infants born in the ...

Grace has Dravet syndrome, a rare and severe form of epilepsy that usually begins within the first year of life. A 2015 study estimates the condition affects up to 1 in 16,000 infants born in the ...

Grace has Dravet syndrome, a rare and severe form of epilepsy that usually begins within the first year of life. A 2015 study estimates the condition affects up to 1 in 16,000 infants born in the ...